StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Leerink Partners Upgrades CVS Health (CVS) to Outperform
February 12, 2025 4:22 PM
Leerink Partners analyst Michael Cherny upgraded CVS Health (NYSE: CVS) from Market Perform to Outperform with a price target of ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Hot Comments
Hot Upgrades
Upgrades
Next Articles
CVS Health (CVS) PT Raised to $76 at Truist Securities
February 13, 2025 6:04 AM